https://www.prnewswire.com/news-releases/genprex-announces-positive-preliminary-preclinical-data-from-study-of-gpx-002-in-type-2-diabetic-animal-studies-302653395.html
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing...
announcespositivepreliminarypreclinicaldata
https://www.multivu.com/players/English/8984051-eyepoint-pharmaceuticals-wet-amd-phase-1-davio-trial-efficacy-results/
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patient
eyepoint pharmaceuticalsreportspositiveinterimsafety
https://www.biospace.com/bloom-science-announces-positive-topline-data-from-a-phase-1-clinical-trial-of-bl-001-a-potential-first-in-class-therapeutic-being-developed-for-both-dravet-syndrome-and-als
Bloom Science, Inc. today announced positive results from its Phase 1 clinical study in healthy volunteers that demonstrate a favorable safety, tolerability...
bloomscienceannouncespositivetopline
https://global.fujitsu/en-global/insight/tl-data-20250409
Unlock the future with data. Discover Fujitsu's DX strategy for achieving net positive, packed with practical knowledge and insights, in our latest report.
net positivedataessentialpromotingapproach
https://www.businesstimes.com.sg/companies-markets/sti-rises-06-positive-data-easing-lockdown-measures
Index up 15.73 points to finish at 2,539.28; key gauges in Japan, Hong Kong and South Korea post modest gains.
positive datastiriseseasinglockdown
https://www.biospace.com/synergy-pharma-to-present-positive-trulance-plecanatide-phase-iii-data-at-b-digestive-disease-week-b-ddw-for-the-treatment-of-irritable-bowel-s
phase iiisynergypharmapresentpositive
https://www.biospace.com/press-releases/zai-lab-presents-positive-phase-1-data-for-zl-1310-a-dll3-targeted-adc-demonstrating-robust-anti-tumor-activity-and-safety-in-patients-with-extensive-stage-small-cell-lung-cancer-at-2025-asco-annual-meeting
zailabpresentspositivephase
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-positive-topline-data-from-phase-ii-clinical-trial-of-lnk01001-in-the-treatment-of-atopic-dermatitis-301895890.html
/PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced positive...
phase iilynkpharmaceuticalsannouncedpositive
https://www.biospace.com/press-releases/emd-serono-presents-positive-phase-2-data-for-enpatoran-demonstrating-reduction-in-disease-activity-in-patients-with-cutaneous-lupus-erythematosus-cle-and-systemic-lupus-erythematosus-sle-with-active-lupus-rash
emd seronopresentspositivephasedata
https://www.biophytis.com/en/july-12-2021/
Biophytis Presents Positive Preclinical Data on Sarconeos (BIO101) in COVID-19 at ECCMID 2021
positivepreclinicaldatacovid
https://www.roche.com/investors/updates/inv-update-2021-01-26
Dear Investor, Please find attached a press release from our partner Regeneron: ...
regeneronreportspositiveinterimdata
https://www.business-standard.com/markets/capital-market-news/euro-gains-traction-against-dollar-ahead-of-us-data-eurinr-in-positive-124022900670_1.html
Euro gained traction during European session on Thursday as dollar turned lower ahead of crucial US PCE data due later today. The US inflation gauge report is...
of useurogainstractiondollar
https://www.biospace.com/senhwa-biosciences-s-positive-topline-cholangiocarcinoma-data-abstract-accepted-by-2021-asco-gastrointestinal-cancers-symposium
Senhwa Biosciences, Inc. announced their Abstract on Cholangiocarcinoma treatment with Silmitasertib has been accepted for oral/poster presentation at the...
biosciencespositivetoplinecholangiocarcinomadata
https://www.biospace.com/sellas-life-sciences-reports-positive-follow-up-immune-response-and-survival-data-in-completed-phase-1-study-of-galinpepimut-s-combined-with-opdivo-in-advanced-malignant-pleural-mesothelioma
SELLAS Life Sciences Group, Inc. announced follow-up clinical/immune-response data from a Phase 1 investigator-sponsored clinical trial of its lead clinical...
life sciencesfollow upimmune responsereportspositive
https://schools2030.org/evidence/listen-schools2030-and-data-must-speak-exploring-positive-deviant-methodology-in-tanzanian-schools/
Nov 9, 2023
positive deviantlistendatamustspeak
https://www.aa.com.tr/en/americas/global-markets-stay-positive-ahead-of-us-inflation-data/3798107
Investors weigh Fed independence concerns after probe involving chair and geopolitical tensions, while tech and defense stock gains offset losses - Anadolu...
global marketsstay positiveof usaheadinflation
https://ourworldindata.org/grapher/positive-rate-daily-smoothed?tab=chart&time=earliest..latest&country=GBR~IRL
DEPRECATED CHART. 7-day rolling average. Comparisons across countries are affected by differences in testing policies and reporting methods.
sharecovidtestspositive
https://www.prnewswire.com/news-releases/calliditas-announces-positive-transform-phase-2b-topline-data-in-primary-biliary-cholangitis-302207350.html
/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today announced that the Phase 2b TRANSFORM trial met its primary...
announcespositivetransformphasetopline
https://interestingengineering.com/culture/microsoft-ai-infrastructure-water-power
Jan 14, 2026 - Microsoft says its U.S. data centers will pay full electricity costs, fund grid upgrades, and replenish more water than they consume.
ai data centerswater positivefull powermicrosoftpledges
https://www.biospace.com/intellipharmaceutics-reports-positive-topline-data-results-from-a-series-of-phase-i-clinical-trials-of-its-abuse-deterrent-rexista-tm-oxycodone-xr-ta
a seriesreportspositivetoplinedata
https://www.psychiatrictimes.com/view/positive-phase-2-data-alixorexton-for-the-treatment-of-adults-with-narcolepsy-type-1?utm_source=www.psychiatrictimes.com&utm_medium=relatedContent
Positive phase 2 results show that treatment with alixorexton led to statistically significant and dose-dependent improvements in sleep latency among patients...
the treatmentpositivephasedataalixorexton
https://stockhouse.com/opinion/independent-reports/2019/09/24/regeneron-reports-positive-phase-3-dupixent-data-gains-eu-approval
Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with...
regeneronreportspositivephasedupixent
https://aviationweek.com/awin-knowledge-center/data-positive-financial-results-us-passenger-cargo-carriers
U.S. passenger and cargo carriers completed the third quarter of 2025 with record operational revenues, newly released statistics show.
results forpassenger cargodatapositivefinancial
https://www.globenewswire.com/news-release/2018/12/01/1660396/0/en/Karyopharm-Reports-Positive-Top-Line-Phase-2b-SADAL-Data-for-Selinexor-in-Patients-with-Diffuse-Large-B-Cell-Lymphoma-at-the-American-Society-of-Hematology-2018-Annual-Meeting.html
-- 29.6% Overall Response Rate Including 9.6% Complete Response Rate -- -- Amongst the Patients with Complete or Partial Response, Median Duration of...
top linereportspositivephasesadal
https://www.ibtimes.co.in/sensex-nifty-turn-positive-after-early-losses-ahead-key-q2-gdp-data-release-893247?utm_source=popunder&utm_medium=pop&utm_campaign=block2-3
Nov 28, 2025 - The Sensex rose 101 points to 85,821, up 0.12 per cent, while the Nifty inched up 35 points to 26,251, a gain of 0.14 per cent. "The Nifty seems likely to...
sensexniftyturnpositiveearly
https://www.prnewswire.com/news-releases/viracta-announces-positive-phase-1b2-data-presented-at-oral-presentation-on-lead-program-for-epstein-barr-virus-ebv-associated-relapsedrefractory-lymphomas-at-the-2019-american-society-of-hematology-ash-annual-meeting-300971007.html
/PRNewswire/ -- Viracta Therapeutics, Inc. (the "Company"), a precision oncology company targeting virus-associated malignancies, announced today that its...
announcespositivephasedatapresented